Harvard Bioscience(HBIO) - 2024 Q1 - Quarterly Results

Exhibit 99.1 | Financial Results Summary | | | Three Months Ended March 31, | | | --- | --- | --- | --- | --- | | (unaudited, $in millions except per share data) | | 2024 | | 2023 | | Revenues |$ | 24.5 | $| 30.0 | | Gross margin | | 60.3$ | (2.3) | $| 1.7 | | Adjusted operating income |$ | 1.2 | $| 4.4 | | Net (loss) income (GAAP) |$ | (4.7) | $| 0.6 | | Diluted (loss) earnings per share (GAAP) |$ | (0.11) | $ | 0.01 | | Diluted adjusted earnings pe ...